Glaucoma is one of the most common causes of permanent blindness in the world. It slowly damages the optic nerve, which is the bundle of nerve fibers that carries visual information from the eye to the brain.
When this nerve becomes damaged, people gradually lose their vision. At first, the changes are usually very subtle and may affect side vision rather than central vision. Because of this, many people do not realize that anything is wrong until the disease has already caused serious and irreversible damage.
The danger of glaucoma lies in the fact that the vision loss cannot be reversed. Once the optic nerve is damaged, the lost sight cannot be restored. For this reason, doctors stress that early detection is the best way to protect vision. If glaucoma is found early, treatments such as eye drops, laser procedures, or surgery can slow the disease and prevent further damage.
However, early detection has always been difficult. Many people do not experience symptoms in the early stages, so they do not visit an eye doctor until vision problems appear. Population-wide screening programs have also been difficult to implement.
Screening large numbers of people requires trained eye specialists, special equipment, and time. In many countries, health systems simply do not have enough specialists to examine everyone who might be at risk.
In recent years, advances in artificial intelligence have opened new possibilities for medical screening. Artificial intelligence systems can analyze medical images and identify patterns that might signal disease. Researchers are now exploring whether AI tools could help detect eye diseases such as glaucoma earlier and more efficiently.
A new study suggests that AI may indeed play an important role. The research was published in the journal The Lancet Primary Care and tested an artificial intelligence screening tool designed to detect signs of glaucoma using images of the eye.
The study took place in 2023 at a screening center in Lisbon, Portugal. Researchers recruited 671 adults between the ages of 55 and 65. This age group was chosen because the risk of glaucoma increases as people grow older.
During the screening, photographs of the participants’ eyes were taken. These images were then analyzed by the AI system to determine whether signs of glaucoma might be present.
To evaluate how well the AI system worked, the same eye images were also reviewed by six glaucoma specialists. These experts carefully examined the images and made their own decisions about whether each person should be referred for further testing.
The results were encouraging. The AI tool recommended referral for 66 people, which represented about 9.8 percent of the participants. In comparison, the eye specialists recommended referral for 118 people, or about 18 percent of the participants.
After further testing, glaucoma was confirmed in 40 participants, which represented about 6.4 percent of the group. The researchers then compared how accurately the AI system and the specialists had identified the disease.
The AI system correctly detected 78 percent of the people who truly had glaucoma. The eye doctors correctly identified 75 percent of these cases. In other words, the AI tool performed slightly better in identifying people who actually had the disease.
The system also performed well in ruling out glaucoma in people who did not have the condition. The AI tool correctly reassured 95 percent of healthy participants that they did not have glaucoma. The eye doctors correctly ruled out the disease in 91 percent of these people.
One of the most important findings of the study was that the AI tool significantly reduced the number of unnecessary referrals. Many people who are referred for further testing turn out not to have glaucoma.
These false alarms can cause stress for patients and increase the workload for hospitals and specialists. By reducing unnecessary referrals by about half, the AI system could make screening programs more efficient and less costly.
The researchers believe that AI-based screening tools could eventually be integrated into routine healthcare settings. For example, eye images could be taken during regular health visits in primary care clinics or pharmacies. The AI system could quickly analyze the images and identify people who need further examination by an eye specialist.
Such an approach could be especially helpful in regions where access to eye doctors is limited. By identifying high-risk patients earlier, AI screening could help prevent avoidable blindness and allow doctors to focus their attention on the patients who need care the most.
However, the researchers also pointed out some limitations in the study. The screening program used in the research was originally designed to monitor eye disease in people with diabetes.
Because of this, a relatively large number of participants in the study had diabetes. Diabetes itself can increase the risk of eye problems, including glaucoma. This means the rate of glaucoma observed in the study may not fully represent the general population.
Further research will be needed to confirm how well the AI system performs in larger and more diverse populations. Scientists will also need to study how such tools can be safely integrated into real healthcare systems.
Overall, the findings of this study suggest that artificial intelligence could become a valuable partner for doctors in detecting glaucoma earlier. The technology does not replace specialists, but it can help them work more efficiently by screening large numbers of people and identifying those most likely to need expert care.
If future studies confirm these results, AI-assisted screening may become an important tool in protecting vision around the world. By helping detect glaucoma earlier and reducing unnecessary referrals, this technology could improve patient care while also easing pressure on healthcare systems.
From an analytical perspective, the study highlights both the promise and the caution needed when introducing AI into healthcare. The improved ability to rule out disease is particularly valuable because it reduces patient anxiety and healthcare costs.
At the same time, the moderate sensitivity in detecting glaucoma shows that AI should still work alongside medical professionals rather than replace them. The results demonstrate that AI can support clinical decision-making, but continued research, testing, and careful implementation will be essential before large-scale adoption.
If you care about eye health, please read studies about how vitamin B may help fight vision loss, and MIND diet may reduce risk of vision loss disease.
For more information about eye disease, please see recent studies about how to protect your eyes from glaucoma, and results showing this eye surgery may reduce dementia risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
